# Advanced Instruments to acquire Nova Biomedical for $2.2 billion

Patricia Industries' subsidiary Advanced Instruments entered a definitive agreement to acquire Nova Biomedical from its founding shareholders for an enterprise value of $2.2 billion. The combined business will operate under the Nova Biomedical name, with 2024 sales of $621 million.

- Type: Acquisition
- Announced: 2025-03-19
- Where: Waltham, Massachusetts, United States
- Value: $2.20B
- Status: announced
- Products: analytical testing instruments, consumables for biopharmaceutical and clinical markets
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Patricia Industries](https://endata.com/companies/3217.md) (investor)
- [Investor AB](https://endata.com/companies/70640.md) (acquirer)
- [Investor AB](https://endata.com/companies/70640.md) (investor)
- [Advanced Instruments](https://endata.com/companies/83599.md) (acquirer)
- [Nova Biomedical](https://endata.com/companies/83600.md) (target)

## Sources

- [novabiomedical.com](https://www.novabiomedical.com/patricia-industries-subsidiary-advanced-instruments-to-acquire-and-merge-with-nova-biomedical/), 2025-03-19: "Patricia Industries’ subsidiary Advanced Instruments has entered into a definitive agreement to acquire Nova Biomedical from its founding shareholders for an enterprise value of USD 2.2bn."
- [roschier.com](https://www.roschier.com/newsroom/advanced-instruments-to-acquire-and-merge-with-nova-biomedical-in-usd-2-2-billion-deal), 2025-03-26: "Advanced Instruments, a subsidiary of Patricia Industries (part of Investor AB), has entered into a definitive agreement to acquire Nova Biomedical from its founding shareholders for an enterprise value of USD 2.2 billion."
- [akm.ru](https://www.akm.ru/eng/news/swedish-investor-acquires-american-nova-biomedical-for-2-2-billion/), 2025-04-20: "Advanced Instruments, a division of the Swedish investment company Investor AB, has signed an agreement to acquire the American medical equipment manufacturer Nova Biomedical for $2.2 billion."
- [newswise.com](https://www.newswise.com/articles/advanced-instruments-to-acquire-and-merge-with-nova-biomedical), 2025-07-23: "Combining these two great companies aligns with our core strategy to develop and commercialize best-in-class technologies that deliver significant customer value across the biopharma and clinical markets."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.